• editor.aipublications@gmail.com
  • Track Your Paper
  • Contact Us
  • ISSN: 2456-8015

International Journal Of Medical, Pharmacy And Drug Research(IJMPD)

Beyond Vision: The Role of Clinical Nutrition in Preventive Ophthalmology and Long-Term Eye Health

Shivani Kalhan Mehra , Dr. S. C. Pahwa , Drishti Pahwa


International Journal of Medical, Pharmacy and Drug Research(IJMPD), Vol-10,Issue-4, October - December 2026, Pages 1-9 , 10.22161/ijmpd.10.4.1

Download | Downloads : 2 | Total View : 61

Article Info: Received: 06 Oct 2026; Received in revised form: 05 Nov 2026; Accepted: 11 Nov 2026; Available online: 16 Nov 2026

Share

The eye is a metabolically active organ whose normal structure and function depend on an adequate supply of energy, essential fatty acids, vitamins, minerals and bioactive compounds. Nutrition is therefore biologically relevant to ocular health across the life course. However, the strength of clinical evidence varies substantially by nutrient and eye condition. This narrative review examines the relationship between dietary patterns, selected micronutrients and common ophthalmic disorders, with emphasis on age-related macular degeneration (AMD), diabetic retinopathy, dry eye disease, cataract and glaucoma. It considers the roles of vitamin A, vitamins C and E, zinc, copper, omega-3 long-chain polyunsaturated fatty acids, lutein and zeaxanthin, while distinguishing mechanistic plausibility and observational associations from demonstrated clinical benefit. The strongest intervention evidence is condition-specific: the Age-Related Eye Disease Study (AREDS) and AREDS2 formulations reduce progression to advanced AMD in appropriately selected people with intermediate AMD or advanced AMD in one eye, but do not prevent AMD onset in the general population. Evidence for routine supplementation to prevent cataract, glaucoma or diabetic retinopathy is insufficient, and trials of omega-3 supplementation for dry eye have produced mixed results. A dietary pattern rich in vegetables, fruits, legumes, whole grains, nuts and appropriate sources of unsaturated fats is a reasonable foundation for general and cardiometabolic health, with potential relevance to ocular health. Nutrition care should complement—not replace—eye examinations, risk-factor management and ophthalmic treatment. Collaborative practice between ophthalmologists and qualified nutrition professionals can support individualized dietary assessment, correction of deficiencies, safe supplement decisions and realistic prevention messaging. This review highlights evidence gaps and proposes an integrated, non-promotional framework for nutrition-informed preventive eye care.

Ocular health; clinical nutrition; preventive ophthalmology; age-related macular degeneration; diabetic retinopathy; dry eye disease; lutein; zeaxanthin; omega-3 fatty acids; dietary patterns.

[1] Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417–1436. doi:10.1001/archopht.119.10.1417.
[2] Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005–2015. doi:10.1001/jama.2013.4997.
[3] Chew EY, Clemons TE, Agrón E, et al. Long-term outcomes of adding lutein/zeaxanthin and omega-3 fatty acids to the AREDS supplements on age-related macular degeneration progression: AREDS2 report 28. JAMA Ophthalmol. 2022;140(7):692–698. doi:10.1001/jamaophthalmol.2022.1640.
[4] National Eye Institute. AREDS/AREDS2 Clinical Trials. Bethesda, MD: National Institutes of Health. Available at: https://www.nei.nih.gov/eye-health-information/clinical-trials/age-related-eye-disease-studies-aredsareds2/about-areds-and-areds2. Accessed November 3, 2026.
[5] National Center for Complementary and Integrative Health. Dietary Supplements for Eye Conditions: What the Science Says. Bethesda, MD: NIH; 2024. Available at: https://www.nccih.nih.gov/health/providers/digest/dietary-supplements-for-eye-conditions-science. Accessed November 3, 2026.
[6] American Academy of Ophthalmology. Diet, Nutrition, and Eye Health Supplements. San Francisco, CA: AAO; 2025. Available at: https://www.aao.org/eye-health/anatomy/diet-nutrition. Accessed November 3, 2026.
[7] Age-Related Eye Disease Study 2 Research Group. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics. Ophthalmology. 2012;119(11):2282–2289. doi:10.1016/j.ophtha.2012.05.027.
[8] Chew EY, Clemons TE, Agrón E, et al. Ten-year follow-up of a randomized trial of lutein/zeaxanthin and omega-3 fatty acids in age-related macular degeneration. JAMA Ophthalmol. 2022; 140(7): 692–698. doi:10.1001/jamaophthalmol.2022.1640.
[9] Age-Related Eye Disease Study 2 Research Group. Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report. JAMA Ophthalmol. 2013;131(7):843–850. doi:10.1001/jamaophthalmol.2013.438.
[10] Dry Eye Assessment and Management (DREAM) Study Research Group. n-3 fatty acid supplementation for the treatment of dry eye disease. N Engl J Med. 2018;378:1681–1690. doi:10.1056/NEJMoa1709691.
[11] Deinema LA, Vingrys AJ, Wong CY, et al. A randomized, double-blind, placebo-controlled clinical trial of topical omega-3 fatty acids for dry eye disease. Invest Ophthalmol Vis Sci. 2017;58(7):3060–3068. doi:10.1167/iovs.16-21368.
[12] Ma L, Dou HL, Wu YQ, et al. Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis. Br J Nutr. 2012;107(3):350–359. doi:10.1017/S0007114511004260.
[13] Johnson EJ. A possible role for lutein and zeaxanthin in cognitive function in the elderly. Am J Clin Nutr. 2012;96(5):1161S–1165S. doi:10.3945/ajcn.112.034611.
[14] SanGiovanni JP, Chew EY, Clemons TE, et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study. Arch Ophthalmol. 2007;125(9):1225–1232. doi:10.1001/archopht.125.9.1225.
[15] World Health Organization. World Report on Vision. Geneva: WHO; 2019. Available at: https://www.who.int/publications/i/item/9789241516570. Accessed November 3, 2026. [15,20]
[16] Flaxel CJ, Adelman RA, Bailey ST, et al. Diabetic Retinopathy Preferred Practice Pattern®. Ophthalmology. 2020;127(1):P66–P145. doi:10.1016/j.ophtha.2019.09.025.
[17] American Diabetes Association Professional Practice Committee. Retinopathy, neuropathy, and foot care: Standards of Care in Diabetes—2024. Diabetes Care. 2024;47(Suppl 1):S231–S243. doi:10.2337/dc24-S012.
[18] Chiu CJ, Taylor A. Nutritional antioxidants and age-related cataract and maculopathy. Exp Eye Res. 2007; 84(2): 229–245. doi:10.1016/j.exer.2006.05.014.
[19] Rasmussen HM, Johnson EJ. Nutrients for the aging eye. Clin Interv Aging. 2013;8:741–748. doi:10.2147/CIA.S45399 տարին.
[20] World Health Organization. Package of Eye Care Interventions. Geneva: WHO; 2022. Available at: https://www.who.int/publications/i/item/9789240048959. Accessed November 3, 2026.